Literature DB >> 21907836

Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF).

Jian Zhao1, Hongxiu Yu, Ling Lin, Jun Tu, Lili Cai, Yanmei Chen, Fan Zhong, Chengzhao Lin, Fuchu He, Pengyuan Yang.   

Abstract

Hepatoma-derived growth factor (HDGF) is a growth factor related to normal development and tumorigenesis; however, the mechanism of its mitogenic and angiogenic activity still remains unknown. Analysis of the HDGF interactome could be important for understanding its function and integrative mechanisms, because knowledge about HDGF interactors is very limited. In this study, through streptavidin-binding peptide (SBP) and Flag tag-based tandem affinity purification (SBP/Flag-TAP) coupled with LC-MS/MS, 106 proteins were shown to form complexes with HDGF. RNAs were also found in the HDGF complex through the SBP-tag based RNA co-immunoprecipitation (SBP-RIP) assay. Some of these interactions were confirmed by Co-IP and RT-PCR. We then found that the HATH domain was essential for HDGF interactions including protein-protein and protein-RNA interactions, and that in the absence of the HATH domain, NO-HATH could not form complex. The interactome suggests that HDGF is a multifunctional protein and participates in many cellular events, including ribosome biogenesis, RNA processing, DNA damage repair and transcriptional regulation. This new information about the HDGF interactome will further our understanding on HDGF-mediated cellular functions.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907836     DOI: 10.1016/j.jprot.2011.08.021

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  9 in total

1.  A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.

Authors:  Ye Song; Zheng Hu; Hao Long; Yuping Peng; Xi'an Zhang; Tianshi Que; Shihao Zheng; Zhiyong Li; Gang Wang; Liu Yi; Zhen Liu; Weiyi Fang; Songtao Qi
Journal:  J Neurooncol       Date:  2014-07-02       Impact factor: 4.130

Review 2.  Proteomics-based methods for discovery, quantification, and validation of protein-protein interactions.

Authors:  Yana V Miteva; Hanna G Budayeva; Ileana M Cristea
Journal:  Anal Chem       Date:  2012-12-12       Impact factor: 6.986

3.  Reinvestigation of aminoacyl-tRNA synthetase core complex by affinity purification-mass spectrometry reveals TARSL2 as a potential member of the complex.

Authors:  Kyutae Kim; Seong-Jun Park; Seungjin Na; Jun Seok Kim; Hyungwon Choi; Yoon Ki Kim; Eunok Paek; Cheolju Lee
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

4.  Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1.

Authors:  Xiao-Hong Liao; Ye Zhang; Wen-Jie Dong; Zhi-Min Shao; Da-Qiang Li
Journal:  Oncotarget       Date:  2017-06-16

5.  Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.

Authors:  Feilong Yang; Nengwang Yu; Hui Wang; Cong Zhang; Zhao Zhang; Yanxiang Li; Dawei Li; Lei Yan; Hainan Liu; Zhonghua Xu
Journal:  PLoS One       Date:  2018-01-04       Impact factor: 3.240

6.  MORC2 regulates DNA damage response through a PARP1-dependent pathway.

Authors:  Lin Zhang; Da-Qiang Li
Journal:  Nucleic Acids Res       Date:  2019-09-19       Impact factor: 16.971

7.  Enhancer LncRNAs Influence Chromatin Interactions in Different Ways.

Authors:  Yue Hou; Rongxin Zhang; Xiao Sun
Journal:  Front Genet       Date:  2019-10-16       Impact factor: 4.599

8.  Hepatoma-derived growth factor and nucleolin exist in the same ribonucleoprotein complex.

Authors:  Stephanie Bremer; Katharina Klein; Angela Sedlmaier; Mekky Abouzied; Volkmar Gieselmann; Sebastian Franken
Journal:  BMC Biochem       Date:  2013-01-10       Impact factor: 4.059

9.  RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells.

Authors:  Ye Zhang; Xiao-Hong Liao; Hong-Yan Xie; Zhi-Min Shao; Da-Qiang Li
Journal:  Oncotarget       Date:  2017-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.